During the past decade, Ospedale Moscati conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Moscati" #1 sponsor was "Gruppo Italiano Trapianto di Midollo Osseo" with 8 trials, followed by "Incyte Corporation" with 2 trials sponsored, "Associazione Angela Serra per la ricerca sul cancro" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Gruppo Oncologico Italiano di Ricerca Clinica" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Moscati" #1 collaborator was "Associazione Italiana di Immunogenetica e Biologia dei Trapianti (AIBT)" with 1 trials as a collaborator, "Azienda Policlinico Umberto I" with 1 trials as a collaborator, "Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia" with 1 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator and "INTERNATIONAL T-CELL NON-HODGKIN'S LYMPHOMA STUDY GROUP" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Moscati" are "Hematologic Diseases" (3 trials), "Myelofibrosis" (3 trials), "Post Essential Thrombocythemia Myelofibrosis" (2 trials), "Post Polycythemia Vera Myelofibrosis" (2 trials) and "Primary Myelofibrosis" (2 trials). Many other conditions were trialed in "Ospedale Moscati" in a lesser frequency.

Most popular intervention types in "Ospedale Moscati" are "Drug" (7 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "parsaclisib" (2 trials), "placebo" (2 trials), "ruxolitinib" (2 trials) and "A: Fludarabine + Busulphan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Moscati" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale Moscati". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Ospedale Moscati, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Moscati, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".